ClinConnect ClinConnect Logo
Search / Trial NCT07055490

Interdisciplinary Practice Bundle for Second-Stage of Labor and Clinical Outcomes

Launched by MANSOURA UNIVERSITY · Jul 3, 2025

Trial Information

Current as of July 14, 2025

Not yet recruiting

Keywords

Bundle Clinical Outcomes Second Satge

ClinConnect Summary

This clinical trial is studying a new approach to care during the second stage of labor, which is the time when a woman is actively pushing to deliver her baby. The goal is to see if using a coordinated plan involving different healthcare professionals can improve delivery outcomes for mothers and babies.

Women who might be eligible to join are first-time mothers over 18 years old, with a healthy pregnancy of at least 38 weeks, and who are expected to have a normal vaginal birth. Women with high-risk pregnancies, medical or psychological conditions, or those likely to need a cesarean section are not eligible. If you participate, you can expect your care team to work closely together during the pushing stage to provide coordinated support. This study is not yet recruiting participants, but it hopes to help improve the experience and safety of childbirth for many women.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • Primiparous women aged greater than 18 years, with normal pregnancy.
  • ≥ 38 weeks of gestation.
  • Eligible for normal vaginal delivery
  • Exclusion Criteria:
  • women with high risk pregnancy.
  • Women with medical or psychological disorders.
  • Women suspected to cesarean birth.

About Mansoura University

Mansoura University is a prestigious academic institution located in Egypt, renowned for its commitment to advancing medical research and education. As a clinical trial sponsor, it leverages its extensive resources and expertise in various fields of healthcare to facilitate innovative research initiatives aimed at improving patient outcomes. The university collaborates with a network of healthcare professionals and researchers to conduct high-quality clinical trials, focusing on addressing critical health challenges through rigorous scientific methodologies. Its dedication to ethical research practices and adherence to regulatory standards underscores its role as a leader in the medical research community.

Locations

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported